Wird geladen...
Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Gene transfer to and correction of hematopoietic stem cells (HSCs) are ideal strategies to cure a number of congenital and acquired disorders. However, transgene products may trigger immunological rejection of modified cells, limiting their therapeutic benefits. Preclinical and clinical data indicat...
Gespeichert in:
| Veröffentlicht in: | Mol Ther Methods Clin Dev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Gene & Cell Therapy
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859277/ https://ncbi.nlm.nih.gov/pubmed/31763350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.10.010 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|